Welcome to the
The aim of our research is to understand the mechanisms underlying chemical-induced toxicity and to develop innovative approaches able to predict with high accuracy the potential adverse effects of chemicals in both humans and wildlife.
Our current research efforts are mainly focused on understanding the effects of environmental chemicals and pharmaceuticals on immune functions and inflammatory responses, and characterising the involvement of those perturbations in the manifestation of chemical-induced or drug-induced adverse health effects.
In parallel with the drug and chemical safety research, we are also interested in understanding the molecular mechanisms underlying specific behavioural phenotypes. Specifically, we study the causal links between chronic inflammation, brain health, and behaviour. This research aims at generating novel mechanistic understanding that can potentially support the identification of more effective therapeutic strategies for patients affected by behavioural disorders.
From a methodological perspective, we integrate computational biology approaches, network biology concepts, and the zebrafish model to investigate important research questions relevant to human and environmental health.
The Margiotta-Casaluci Lab is based at King's College London, School of Cancer and Pharmaceutical Sciences.
Brunel University London
New lab member
Welcome to the BMSRC MSc student Erin Suriawinata, who joined our lab to carry out her MSc research project. Erin will combine in silico and in vivo methods to investigate the immunomodulatory potential of pollutants.
New lab member
Welcome to Titilayo Soyombo (Titi), who joined our lab to carry out her final year BSc research project. Titi will study the effects of pro-inflammatory molecules on zebrafish behaviour.
We are hiring!
Fully funded 4-year BBSRC iCASE PhD position available in our lab (in collaboration with AstraZeneca) - Read more here: https://tinyurl.com/3d8edmsd - Deadline 10 January 2023
approaches for the prediction of drug
We provide custom-tailored Adverse Outcome Pathway (AOP)-development to support the identification of effective mode-of-action-driven chemical testing strategies.
Chemical risk assessment
Thanks to our 13-year experience in mode-of-action toxicology, we can help you to decide cost-effective and scientifically sound strategies to facilitate the integration of advanced mechanistic considerations into the traditional environmental risk assessment (ERA) of pharmaceuticals and other chemicals. We also provide custom-made data visualisation strategies to facilitate inter-stakeholder communication and support regulatory decision-making.
Contact us for more details
LUIGI MARGIOTTA-CASALUCI, PhD
Group Leader, Principal Investigator
Senior Lecturer in Toxicology
Luigi is a Senior Lecturer in Toxicology, and Group Leader at King's College London with more than 15 years of experience in the study of mode-of-action-driven toxicology of pharmaceuticals and cross-species extrapolation. He earned his PhD in Environmental Toxicology from Brunel University London in 2011 ( sponsored by GlaxoSmithKline), under the supervision of Professor John Sumpter OBE, working on the extrapolation of pharmacological and toxicological data between zebrafish, mammalian pre-clinical models, and humans. Luigi continued to develop his research interests in comparative pharmacology during a 4-year BBSRC/AstraZeneca-funded Post-Doc at AstraZeneca and Brunel University London, where he started his independent research group in 2015. In 2021, Luigi started a Senior Lecturer (Associate Professor) position at King's College London.
RESEARCH ASSOCIATE and DATA SCIENTIST
Ben is data scientist and registered associate nutritionist interested in research areas such as human disease, nutrition, sports science and pharmacology. He joined the DEVINA team in January 2022, and since then he has been developing a novel and exciting data platform - integrated with intuitive data viz - that will become a reference tool for any stakeholder interested in the use of toxicity data to support regulatory decision making.
Philip is PhD candidate, holding a 4-year BBSRC/AstraZeneca PhD studentship. His research is aimed at exploring the immune-mediated effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs, such as ibuprofen, diclofenac, celecoxib), and at characterising the phenotypic relevance of NSAIDs-target interaction networks, beyond cyclo-oxygenases (COXs) inhibition. Before joining the Margiotta-Casaluci Lab at Brunel University London, Philip graduated in Biomedical Sciences at the University of Sheffield (UK) and gained industry experience working at Oxford Immunotec.
Ines is PhD candidate, holding a 3-year Isambard PhD studentship. Her research is aimed at characterising the relationship between gut inflammation and behavioural disorders, bridging zebrafish research, human-relevant experimental data, and clinical observations. Ines graduated in Environmental Health at the Polytechnic Institute of Oporto (Portugal), and earned her master's in Toxicology And Risk Assessment from Brunel University London (UK).
CURRENT BSc and MSc INTERNS
BSc Final Year Projects and MSc Dissertations
Salwa Zabir (Biomedical and Molecular Sciences MSc)
Investigating the immunomodulatory effects of environmental chemicals
Salwa is the recipient of a prestigious Matt Wilson Scholarship, which provides added-value to a research project by enabling costly experiments to be performed that otherwise would not be possible.
Matthew (“Matt”) Wilson studied at King’s College London and obtained an MSc in “Biomedical and Molecular Sciences Research” in October 2011. He graduated with Distinction, ranked 2nd of 33 students, notably whilst undergoing treatment for cancer throughout his studies.
We are honoured to be the recipient of this Scholarship and we are committed to carry out outstanding research and ensure that Matt’s legacy lives on!
Sebastian Millard (Analytical Toxicology MSc)
PK/PD of metformin across species
Junyan Xu (Analytical Toxicology MSc)
Uptake and PK of phsycoactive drugs in zebrafish larvae
(2022) Environmental Occurrence and Predicted Pharmacological Risk to Freshwater Fish of over 200 Neuroactive Pharmaceuticals in Widespread Use.
Sumpter, J.P.; Margiotta-Casaluci, L. Toxics 10(5):233. Link
(2022) COVID-19 through adverse outcome pathways: Building networks to better understand the disease – 3rd CIAO AOP Design Workshop
Clerbaux, L-A.; (...) Margiotta-Casaluci, L.; (...) Wittwehr, C. ALTEX 39(2): 322-335. Link
(2022) Are synthetic glucocorticoids in the aquatic environment a risk to fish?
Hamilton, C.M; Winter, M.J.; Margiotta-Casaluci, L.; Owen, S.F.; Tyler, C.R. Environment International 162, 107163. Link
(2021) Pharmacology-informed prediction of the risk posed to fish by mixtures of non-steroidal anti-inflammatory drugs (NSAIDs) in the environment.
Marmon, P.; Owen, S.F.; Margiotta-Casaluci, L. Environment International 146, 106222. Link
(2020) New ideas for non-animal approaches to predict repeated-dose systemic toxicity: Report from an EPAA Blue Sky Workshop.
Mahony, C.; Ashton, R.S.; Birk, B.; Boobis, A.R.; Cull, T,; Daston, G.P.; Ewart, L.; Knudsen, T.B.; Manou, I.; Maurer-Stroh, S.; Margiotta-Casaluci, L.; Müller, B.P.; Nordlund, P.; Roberts, R.A.; Steger-Hartmann, T.; Vandenbossche, E.; Viants, M.R.; Vinken, M.; Cronin. Regulatory Pharmacology and Toxicology 114, 104668. Link
(2020) Toxicology advances for 21st century chemical pollution.
Brooks, B.W.; Sabo-Attwood, T.; Choi, K.; Kim, S.; Kostal, J.; LaLone, C.A.; Langan, L.M.; Margiotta-Casaluci, L.; You, J.; Zhang, X. One Earth 2:312-316. Link
(2020) The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds.
Legler, J.; Zalko, D.; Jourdan, F.; Jacobs, M.; Fromenty, B.; Balaguer, P.; Bourguet, W.; Munic Kos, V.; Nadal, A.; Beausoleil, C.; Cristobal, S.; Remy, S.; Ermler, S.; Margiotta-Casaluci, L.; Griffin, J.L.; Blumberg, B.; Chesné, C.; Hoffmann, S.; Andersson, P.L.; Kamstra, J.H., on behalf of the GOLIATH Consortium; Int. J. Mol. Sci. 21, 3480. Link
(2020) Vision of a near future: Bridging the human health–environment divide. Toward an integrated strategy to understand mechanisms across species for chemical safety assessment.
Rivetti C; Allen TEH; Brown JB; Butler B; Carmichael PL; Colbourne JK; Dent M; Falciani F; Gunnarsson L; Gutsell S; Harrill JA; Hodges G; Jennings P; Judson R; Kienzler A; Margiotta-Casaluci L; Muller I; Owen SF; Rendal C; Russell PJ; Scott S; Sewell F; Shah I; Sorrel I; Viant MR; Westmoreland C; White A; Campos B. Toxicology in Vitro 104692. Link
(2020) Immunoassays are not immune to errors: examples from two studies of steroid output from freshwater trout farms.
Ellis T; Waring CP; Margiotta-Casaluci L; Pottinger TG; Morris S; Reese A; Sumpter JP; Scott AP. General and Comparative Endocrinology 285,113226. Link
(2019) Testing the translational power of the zebrafish: an inter-species analysis of responses to cardiovascular drugs.
Margiotta-Casaluci L; Owen SF; Rand-Weaver, M; Winter MJ. Frontiers in Pharmacology 10, 893. Link
(2019) Pharmacology beyond the patient – the environmental risk of human drugs.
Gunnarsson L; Snape J; Verbruggen B; Owen S; Kristiansson E; Margiotta-Casaluci L; Österlund T; Hutchinson K; Leverett D; Marks B; Tyler CR. Environment International 129,320-332. Link
(2019) Protecting the environment from psychoactive drugs: problems for regulators illustrated by the possible effects of tramadol on fish behaviour.
Tanoue R; Margiotta-Casaluci L; Huerta B; Runnalls TJ; Eguchi A; Nomiyama K; Kunisue T; Tanabe S; Sumpter JP. Science of the Total Environment 664,915-926. Link
(2018) Adverse Outcome Pathway Networks I: Development and Applications.
Knapen D; Angrish MM; Fortin MC; Katsiadaki I; Leonard M; Margiotta- Casaluci L; Munn S; O’Brien JM; Pollesch N; Smith C; Zhang X; Villeneuve DL. Environmental Toxicology and Chemistry 37,1723-1733. Link
(2018) Adverse Outcome Pathway Networks II: Network Analytics.
Villeneuve, D.L., Angrish, M.M., Fortin, M.C., Katsiadaki, I., Leonard, M., Margiotta-Casaluci, L., Munn, S., O’Brien, J.M., Pollesch, N., Smith, C., Zhang, X., Knapen, D. Environmental Toxicology and Chemistry 37,1734-1748. Link
(2017) Uptake and Metabolism of Human Pharmaceuticals by Fish—A Case Study with the Opioid Analgesic Tramadol.
Tanoue, R., Margiotta-Casaluci, L., Huerta, B., Runnalls, T.J., Nomiyama, K., Kunisue, T., Tanabe, S., Sumpter, J.P. Environmental Science and Technology 51,12825-12835. Link
(2016) Internal exposure dynamics drive the Adverse Outcome Pathways of synthetic glucocorticoids in fish.
Margiotta-Casaluci, L., Owen, S.F., Huerta, B., Rodríguez-Mozaz, S., Kugathas, S., Barceló, D., Rand-Weaver, M., Sumpter, J.P. Scientific Reports 6. Link
(2016) Anti-anxiety drugs and fish behaviour: establishing the link between internal concentrations of oxazepam and behavioural effects.
Huerta, B., Margiotta-Casaluci, L., Rodríguez-Mozaz, S., Scholze, M., Winter, M.J., Barceló, D., Sumpter, J.P.
Environmental Toxicology and Chemistry 35(11),2782-2790. Link
(2015) From single chemicals to mixtures: reproductive effects of levonorgestrel and ethinylestradiol in the fathead minnow.
Runnalls, T.J.; Beresford, N.; Kugathas, S.; Margiotta-Casaluci, L.; Scholze, M.; Scott, A.P.; Sumpter, J.P. Aquatic Toxicology 169,152-167. Link
(2014) Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.
Margiotta-Casaluci, L.; Owen S.F.; Cumming, R.I.; de Polo, A.; Winter, M.J.; Panter, G.H.; Rand-Weaver, M.; Sumpter, J.P. PLoS ONE 9 (10). Link
(2014) A new role of carbonic anhydrase II in the response of fish to copper and osmotic stress: implications for multi-stressor studies.
de Polo, A.; Margiotta-Casaluci, L.; Lockyer, A.E.; Scrimshaw, M.D. (2014) PLoS ONE 9 (10). Link
(2014) An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment.
Caldwell, D.J.; Mastrocco, F.; Margiotta-Casaluci, L.; Brooks, B.W. Chemosphere 115, 4-12. Link
(2014) Are some invertebrates exquisitely sensitive to the human pharmaceutical Fluoxetine?
Sumpter, J.P.; Margiotta-Casaluci, L. Aquatic Toxicology 146,259-260. Link
(2013) The Read-Across Hypothesis and Environmental Risk Assessment of Pharmaceuticals.
Rand-Weaver, M.; Margiotta-Casaluci, L.; Patel, A.; Panter, G.H.; Owen, S.F.; Sumpter, J.P. Environmental Science and Technology 47(20),11384–11395. Link
(2013) Mode of action of human pharmaceuticals in fish: The effects of the 5-alpha-reductase inhibitor, dutasteride, on reproduction as a case study.
Margiotta-Casaluci, L., Hannah, R.E., Sumpter, J.P. Aquatic Toxicology 128-129,113-123. Link
(2013) Identification and quantification of 5α-dihydrotestosterone in the teleost fathead minnow (Pimephales promelas) by gas chromatography-tandem mass spectrometry.
Margiotta-Casaluci, L.; Courant, F.; Antignac, J.P.; Le Bizec, B.; Sumpter, J.P. General and Comparative Endocrinology 191,202- 209. Link
(2011) Preliminary data on the influence of rearing temperature on the growth and reproductive status of fathead minnows (Pimephales promelas).
Brian, J.V., Beresford, N., Margiotta-Casaluci, L., Sumpter J.P. Journal of Fish Biology 79,80-88. Link
(2011) 5α-Dihydrotestosterone is a potent androgen in the fathead minnow (Pimephales promelas).
Margiotta-Casaluci, L., Sumpter, J.P. General and Comparative Endocrinology 171,309-318. Link
(2010) Pharmaceuticals in the aquatic environment: steroids and anti-steroids as high priorities for research.
Runnalls, T.J.*, Margiotta-Casaluci, L.*, Kugathas, S. and Sumpter, J.P. International Journal of Human and Ecological Risk Assessment 6,1318-1338. (*Co-first authorship). Link